N@N

Fresenius Medical Care AG & Co KGaA (NYSE:FMS), Up By 6.35% ($4.52) From $71.230 After BUYINS.NET Report Predicted Strength Bef

^{Published on 2012-10-05 07:42:18 - WOPRAI}
 

October 5, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Friday, September 21st 2012 stating that Fresenius Medical Care AG & Co KGaA (NYSE:FMS) was expected to be Up Before its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=fms&id=312228

At the time this story was written, Fresenius Medical Care AG & Co KGaA (NYSE:FMS) is Up By 6.35% ($4.52) From $71.230 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

Fresenius Medical Care AG & Co KGaA (NYSE:FMS) - Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, offers dialysis treatment services through its clinics. As of December 31, 2009, the company provided dialysis treatment to 195,651 patients in 2,553 clinics worldwide located in approximately 35 countries. It also performs clinical laboratory testing services, including blood, urine, and other bodily fluid testing services, as well as provides inpatient dialysis and other services under contract to hospitals. In addition, the company develops and manufactures a range of equipment, systems, and disposable products, including hemodialysis (HD) machines, modular components for dialysis machines, polysulfone dialyzers, bloodlines, HD solutions and concentrates, needles, connectors, machines for water treatment, data administration systems, and dialysis chairs; Phoslo and Venofer iron products, and other renal drug products; and arterial, venous, single needle, and pediatric bloodlines, as well as automated peritoneal dialysis equipment. Fresenius Medical Care sells its products directly and through distributors to clinics, hospitals, and specialized treatment clinics. The company was founded in 1996 and is headquartered in Bad Homburg, Germany..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Fresenius Medical Care AG & Co KGaA (NYSE:FMS) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net